Reading NGVT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track NGVT free→Reading NGVT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track NGVT free→QuarterlyIQ Insights · NGVT
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On May 6, 2026 , Ingevity Corporation ("Ingevity") announced its preliminary financial results for the three months ended March 31, 2026 which are attached as Exhibit 99.1 to this Current Report on Form 8-K. Please refer to our website for additional information regarding Ingevity. Periodically we may provide other information on the investor relations page of our website. Interested parties are encouraged to visit Ingevity's website to view such…
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On April 29, 2026, Ingevity Corporation (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). At the Annual Meeting, upon the recommendation of the Company’s Board of Directors, the Company’s stockholders approved the Amendment to the Ingevity Corporation 2025 Omnibus Incentive Plan (the “Amendment”). The Amendment increas…
Creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of a registrant The information in
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT On March 26, 2026 (the “ Closing Date ”), Ingevity Corporation (the “ Company ”), Ingevity Holdings SRL (“ Holdings ”), Ingevity UK Ltd (the “ UK Borrower ”), the other loan parties party thereto, the lenders party thereto, the issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “ Administrative Agent ”), collateral agent and swingline lender, entered into that certain Second Amendment and Restatement Agreement (th…
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On February 25, 2026 , Ingevity Corporation ("Ingevity") announced its preliminary financial results for the three and twelve months ended December 31, 2025, which are attached as Exhibit 99.1 to this Current Report on Form 8-K. Please refer to our website for additional information regarding Ingevity. Periodically we may provide other information on the investor relations page of our website. Interested parties are encouraged to visit Ingevity's…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On February 17, 2026, Jean S. Blackwell informed the Nominating & Governance Committee of the Board of Directors (the “Board”) of Ingevity Corporation (the “Company”) that she will not stand for election at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”). Ms. Blackwell will continue to serve as a director through the da…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On October 23, 2025, Ingevity Corporation (“Ingevity” or the “Company”) announced that it has appointed Ruth Castillo as Senior Vice President and President, Performance Materials of the Company, effective as of November 10, 2025. Ms. Castillo will report directly to Ingevity’s President and Chief Executive Officer. Biographical Information Ms. Cast…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.